These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20920444)

  • 21. A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes.
    Wong M; Abdulnabi R; Carey MA; Fu H
    Curr Med Res Opin; 2013 May; 29(5):465-73. PubMed ID: 23438454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen.
    Kappes CM; Kershner JR; Morwick TM; Corrigan SM
    J Diabetes Sci Technol; 2018 Mar; 12(2):364-372. PubMed ID: 29084452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.
    Klonoff D; Nayberg I; Rabbone I; Domenger C; Stauder U; Oualali H; Danne T
    J Diabetes Sci Technol; 2015 May; 9(3):625-31. PubMed ID: 25633967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.
    Wang T; Conrad KA; van Brunt K; Rees TM
    J Diabetes Sci Technol; 2016 Jul; 10(4):923-31. PubMed ID: 26920640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceptions of Insulin Pen Use and Technique in Black and Hispanic/Latino Patients with Type 2 Diabetes: a Qualitative Study.
    Myers AK; Gulati N; Pascarelli B; Finuf K; Hahn AL; Bissoonauth AB; Pekmezaris R
    J Racial Ethn Health Disparities; 2020 Oct; 7(5):949-957. PubMed ID: 32124421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?
    Lefkowitz M
    J Diabetes Sci Technol; 2011 Jan; 5(1):136-49. PubMed ID: 21303636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch
    Asakura T; Suzuki S; Aranishi T; Cai Z
    Curr Med Res Opin; 2018 Jun; 34(6):1117-1124. PubMed ID: 29504812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals.
    Pfützner A; Bailey T; Campos C; Kahn D; Ambers E; Niemeyer M; Guerrero G; Klonoff D; Nayberg I
    Curr Med Res Opin; 2013 May; 29(5):475-81. PubMed ID: 23402225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism.
    Clarke A; Dain MP
    Expert Opin Drug Deliv; 2006 Sep; 3(5):677-83. PubMed ID: 16948562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of insulin pen devices.
    McCoy EK; Wright BM
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Control of diabetes mellitus with the insulin pen. Adequately managed?].
    van der Loos TL
    Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1183-4. PubMed ID: 2664533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes.
    LaRue S; Malloy J
    J Diabetes Sci Technol; 2015 Jul; 9(4):815-21. PubMed ID: 25759181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
    Matfin G; Van Brunt K; Zimmermann AG; Threlkeld R; Ignaut DA
    J Diabetes Sci Technol; 2015 Apr; 9(5):1071-9. PubMed ID: 25901022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.